Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Preventing Atrial Fibrillation After Valve Repair
NCT02084069Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in Atrial fibrillation (AFib), sponsored by Urmia University of Medical Sciences. Started Jan 2013; status: completed.
02
Drugs
atorvastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02084069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084069.